Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP480182.RAUhd0CVHeFGZAdysvo5r1oUU1G0BEX6l6WGyKfDa9iL8130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP480182.RAUhd0CVHeFGZAdysvo5r1oUU1G0BEX6l6WGyKfDa9iL8130_provenance.
• NP920295.RAruG9zzjOQts1g_6ENtIWATGPdPWPgHC-CTDCwecyQsE130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP920295.RAruG9zzjOQts1g_6ENtIWATGPdPWPgHC-CTDCwecyQsE130_provenance.
• NP577498.RAjvTWUET32J6ntOxMV40ltcNV3woStTX9Syeo0c3Jkr0130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577498.RAjvTWUET32J6ntOxMV40ltcNV3woStTX9Syeo0c3Jkr0130_provenance.
• NP718349.RAdHOerUgYT8GTbtvUueIifPB0H4fXw3hgOk4zAOuWAVI130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718349.RAdHOerUgYT8GTbtvUueIifPB0H4fXw3hgOk4zAOuWAVI130_provenance.
• assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP384785.RAZQSfKFsM9kHSKqdaH9ceo-VHmvDdFl_UYh96bzP_OSY130_provenance.
• NP390251.RASLknRvUvZMMivUJfoFKbolbJH11GTn-gSR9GMisaJ5E130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP390251.RASLknRvUvZMMivUJfoFKbolbJH11GTn-gSR9GMisaJ5E130_provenance.
• NP857830.RA7w1vR06aK0hJsoVsuo27oNSqA8V2hDn56jhXcoIRsqs130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857830.RA7w1vR06aK0hJsoVsuo27oNSqA8V2hDn56jhXcoIRsqs130_provenance.
• NP957251.RAlkthwAUqQ1OBMsGR3Rgfx48tlA9uk18Z1JEjSj6Jz5Q130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957251.RAlkthwAUqQ1OBMsGR3Rgfx48tlA9uk18Z1JEjSj6Jz5Q130_provenance.
• NP957252.RAG_ofv5cvTsCE_ztIuA6Myo-FewXcMF6JcISxBgylXtY130_assertion description "[Notably, tissue-microarray analyses from an established cohort of women diagnosed with invasive breast carcinoma exhibited a significantly shorter disease-free (P=0.006) and overall (P=0.02) survival of patients that were positive for ER and PAR(1), compared to ER-positive but PAR(1)-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP957252.RAG_ofv5cvTsCE_ztIuA6Myo-FewXcMF6JcISxBgylXtY130_provenance.